NLRP3 and hepatocellular carcinoma: In Figure 4A,B, HCC development and metastasis was significantly delayed in mice implanted with NLRP3 KO(−/−) HCC cells compared to mice implanted with NLRP3 WT(+/+) HCC cells (n = 6; p < 0.05), and this was more when intraperitoneally injected with NK-92 cells (2 × 106 cells/mouse, untreated vs. treated; p < 0.05).